Jake Leach became DexCom’s chief executive on January 1 and is trying to write the turnaround story of this innovative medtech company. One story to tell is how CGMs should be a no-brainer for type 2 diabetes patients on GLP-1 weight loss drugs. The post DexCom’s CEO Believes Diabetics On GLP-1s Should Also Wear CGMs…
Array Behavioral Care introduced a new model called Care Pathways, which aims to make mental health treatment more consistent and personalized while also improving patient outcomes. The post Array Behavioral Care Introduces Model for Standardizing Mental Health Treatment appeared first on MedCity News.
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization. The post Building Service Infrastructure for “Made-To-Order” Therapies appeared first on MedCity News.
This isn’t a political issue, it’s a public health challenge with real consequences for kids’ futures. As reality sets in, we must face the possibility of a post-fluoridation era and find new ways to give kids in at-risk communities a fair shot at a healthy smile. The post Beyond Politics: Payer Solutions for Fluoride-free Communities…
Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through the program include Hinge Health, Rula, Talkspace and Omada. The post Amazon Adds Teladoc Health to Health Benefits Program appeared first on MedCity News.
Ahead of the Trump administration’s planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicare’s negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMS’s Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being…
The Alliance for Connected Care, the American Telemedicine Association and numerous other organizations sent a letter to the DEA urging action to safeguard remote prescribing of controlled substances. The post Over 200 Organizations Call on DEA to Continue Remote Prescribing of Controlled Substances appeared first on MedCity News.
This may be the best comeback performance of all time. Not only did Lindsey Vonn come out of retirement to race a World Cup downhill at age 40 but she placed 6th and did it on an artificial knee! Here’s the details on the surgery but first watch her performance and just look how happy…
Injectable Leqembi permits weekly maintenance dosing of the Eisai and Biogen Alzheimer’s disease drug that may be done at a patient’s home. Other recent notable regulatory new include several rare disease drug approvals and narrower FDA nods for Covid-19 vaccines. The post Alzheimer’s Therapy Is Coming to the Home With FDA Approval of Injectable Eisai,…
Gilead Sciences’ Trodelvy did not meet the main overall survival goal of its confirmatory Phase 3 test. The antibody drug conjugate was awarded accelerated approval for advanced urothelial carcinoma in 2021. The post Gilead Sciences Voluntarily Pulls Drug for Bladder Cancer After Trial Failure appeared first on MedCity News.